CLINICAL_TRIALS
trial_result
· 2018-04-02
Clinical Trial Update: Dose-finding Study in Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
Summary
A dose-finding study in recurrent platinum-resistant ovarian cancer completed Phase 1/Phase 2 with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Accenture | Conditions: Recurrent Platinum-resistant Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-02